YIFAN PHARMACEUTICAL(SZ:002019) Xin Lang Cai Jing·2026-01-05 03:12Group 1 - Yifan Pharmaceutical's stock increased by 5.1%, reaching 12.57 CNY per share, with a trading volume of 204 million CNY and a turnover rate of 1.96%, resulting in a total market capitalization of 15.29 billion CNY [1] - The company, established on November 10, 2000, and listed on July 13, 2004, is located in Lin'an District, Hangzhou, Zhejiang Province, and primarily engages in the production and sale of active pharmaceutical ingredients and high polymer materials [1] - The revenue composition of Yifan Pharmaceutical includes self-owned pharmaceutical products (including imports) at 75.52%, vitamins at 11.47%, other pharmaceutical products at 9.52%, high polymer materials at 3.00%, and pharmaceutical services at 0.49% [1] Group 2 - Jin Yuan Shun An Fund has a significant holding in Yifan Pharmaceutical, with the Jin Yuan Shun An Baoshi Dynamic Mixed Fund (620001) holding 112,000 shares, accounting for 3.48% of the fund's net value, making it the eighth largest holding [2] - The Jin Yuan Shun An Baoshi Dynamic Mixed Fund was established on August 15, 2007, with a latest scale of 44.6294 million CNY, achieving a year-to-date return of 11.82% and a one-year return of 11.82%, ranking 5551 out of 8155 in its category [2] Group 3 - The fund manager of Jin Yuan Shun An Baoshi Dynamic Mixed Fund is Kong Xiangpeng, who has been in the position for 8 years and 194 days, with a total fund asset size of 14.3 million CNY, and has experienced a best return of -1.71% and a worst return of -11.58% during his tenure [3] - Co-manager Shang Changceng has been in the role for 2 years and 72 days, managing assets of 44.6291 million CNY, with a best return of 14.04% and a worst return of 0.05% during his tenure [3]